Q4 EPS Estimate for Cooper Companies Boosted by Analyst

The Cooper Companies, Inc. (NASDAQ:COO) – Investment analysts at William Blair increased their Q4 2025 EPS estimates for shares of Cooper Companies in a research note issued on Monday, December 9th. William Blair analyst M. Andrew now anticipates that the medical device company will post earnings per share of $1.08 for the quarter, up from their previous forecast of $1.07. The consensus estimate for Cooper Companies’ current full-year earnings is $3.98 per share.

Several other analysts have also weighed in on COO. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Wells Fargo & Company lifted their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Piper Sandler raised their price target on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Finally, Morgan Stanley lowered their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $96.72 on Wednesday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $19.26 billion, a price-to-earnings ratio of 49.60, a price-to-earnings-growth ratio of 2.17 and a beta of 0.97. Cooper Companies has a twelve month low of $84.76 and a twelve month high of $112.38. The business has a 50 day simple moving average of $103.71 and a 200-day simple moving average of $98.87.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same period in the previous year, the company earned $0.87 earnings per share. Cooper Companies’s quarterly revenue was up 9.8% on a year-over-year basis.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in COO. Ashton Thomas Securities LLC acquired a new position in Cooper Companies during the third quarter valued at $25,000. Innealta Capital LLC acquired a new stake in Cooper Companies during the second quarter valued at $25,000. Covestor Ltd grew its stake in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after purchasing an additional 200 shares in the last quarter. Crewe Advisors LLC increased its position in Cooper Companies by 286.4% in the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after purchasing an additional 252 shares during the last quarter. Finally, Tortoise Investment Management LLC raised its stake in shares of Cooper Companies by 75.4% during the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after purchasing an additional 169 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the transaction, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. This trade represents a 41.03 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 2.00% of the stock is owned by insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.